Literature DB >> 21135359

The contradiction of appropriate shocks in primary prevention ICDs: increasing and decreasing the risk of death.

Michael O Sweeney.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 21135359     DOI： 10.1161/CIRCULATIONAHA.110.000208

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  6 in total

Review 1.  Treatment of ventricular tachycardia in patients with heart failure.

Authors:  Michael W Fong; Luanda Grazette; David Cesario; Michael Cao; Leslie Saxon
Journal:  Curr Cardiol Rep       Date:  2011-06       Impact factor: 2.931

2.  Evaluation of acute cardiac and chest wall damage after shocks with a subcutaneous implantable cardioverter defibrillator in Swine.

Authors:  Cheryl R Killingsworth; Sharon B Melnick; Silvio H Litovsky; Raymond E Ideker; Gregory P Walcott
Journal:  Pacing Clin Electrophysiol       Date:  2013-05-28       Impact factor: 1.976

3.  Incidence of nonphysiologic short VV intervals detected by the sensing integrity counter with integrated bipolar compared with true bipolar leads: clinically inconsequential or cause for concern?

Authors:  Justin Ng; Nagesh Chopra; Chirag Barbhaiya; Tobias Reichlin; Eyal Nof; Koichi Nagashima; Thomas Tadros; Bruce A Koplan
Journal:  J Interv Card Electrophysiol       Date:  2014-02-16       Impact factor: 1.900

4.  Ventricular Tachycardia Ablation - The Right Approach for the Right Patient.

Authors:  Mouhannad M Sadek; Robert D Schaller; Gregory E Supple; David S Frankel; Michael P Riley; Mathew D Hutchinson; Fermin C Garcia; David Lin; Sanjay Dixit; Erica S Zado; David J Callans; Francis E Marchlinski
Journal:  Arrhythm Electrophysiol Rev       Date:  2014-11-29

5.  Catheter Ablation for Ventricular Arrhythmias.

Authors:  Eyal Nof; William G Stevenson; Roy M John
Journal:  Arrhythm Electrophysiol Rev       Date:  2013-04

6.  Impact of shocks on mortality in patients with ischemic or dilated cardiomyopathy and defibrillators implanted for primary prevention.

Authors:  Florian Streitner; Thomas Herrmann; Juergen Kuschyk; Siegfried Lang; Christina Doesch; Theano Papavassiliu; Ines Streitner; Christian Veltmann; Dariusch Haghi; Martin Borggrefe
Journal:  PLoS One       Date:  2013-05-10       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.